As those of us that can work from home adapt to what our days will look like for the foreseeable, here are a few little tips for ensuring the ‘new normal’ works for you as much as possible.
Our offices are currently closed for the safety of our staff, but our main numbers have been diverted to consultants’ mobiles. Please call 01225 336 335 for our Bath team, or 0161 914 7660 for our Manchester team.
NICE recommends Bayer’s MS treatment, complementary cancer therapies ‘do more harm than good’, Daiichi Sankyo announces results of Phase 3 CLEAR Wisdom trial, and could greater collaboration accelerate much-needed treatments for children with rare diseases?
The NIHR is to invest £34 million into global health research projects within low and middle-income countries, a ‘DIY’ alternative to traditional smear tests is ‘promising’, and the BBC shares 10 charts that show why the NHS does matter in the upcoming UK election.
A new healthtech research institute is to launch in Manchester, a molecular diagnostics player raises £12.3m to develop an instrument-free portfolio, Siemens acquires Corindus Vascular Robotics, and can Alexa be trusted with our health questions?
Top roles from Star this month include Senior Brand Manager, Associate Director, Key Account Manager and Senior Marketing Manager positions within a range of areas including Drug Delivery, Oncology and Medical Affairs, and across national locations!
GSK agrees to divest rabies and tick-borne encephalitis vaccines, there’s further research into personalised breast cancer treatment, the finalists for the PT Sales Awards are revealed, and search results suggest consumers are at risk of buying fake pharma products online.
On the face of it, selling to the NHS is the same regardless of what your product is, whether that be within devices or pharmaceuticals. However, on closer inspection there are major differences between selling a drug to selling a device.
In the news this week: the CQC publishes its 2019 ‘State of Care’ report, the government proposes a new patient safety regulator, an inexpensive drug could ‘save thousands of lives a year’ from head injuries, and could British HIV-positive patients living in Spain lose their healthcare post-Brexit?
An innovation that combines data analytics and wearable technology to prevent falls is shortlisted in an awards category, the Axis-D pen-injector tech is to be licensed for development in diabetes treatment, and Northern Ireland’s Stormont is given £31m to prepare for a no-deal Brexit.